The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Protein corona: a new approach for nanomedicine design
Open accessAbstract
After administration of nanoparticle (NP) into biological fluids, an NP-protein complex is formed, which represents the "true identity" of NP in our body. Hence, protein-NP interaction should be carefully investigated to predict and control the fate of NPs or drug-loaded NPs, including systemic circulation, biodistribution, and bioavailability. In this review, we mainly focus on the formation of protein corona and its potential applications in pharmaceutical sciences such as prediction modeling based on NP-adsorbed proteins, usage of active proteins for modifying NP to achieve toxicity reduction, circulation time enhancement, and targeting effect. Validated correlative models for NP biological responses mainly based on protein corona fingerprints of NPs are more highly accurate than the models solely set up from NP properties. Based on these models, effectiveness as well as the toxicity of NPs can be predicted without in vivo tests, while novel cell receptors could be identified from prominent proteins which play important key roles in the models. The ungoverned protein adsorption onto NPs may have generally negative effects such as rapid clearance from the bloodstream, hindrance of targeting capacity, and induction of toxicity. In contrast, controlling protein adsorption by modifying NPs with diverse functional proteins or tailoring appropriate NPs which favor selective endogenous peptides and proteins will bring promising therapeutic benefits in drug delivery and targeted cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Cedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Aggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Protein-nanoparticle interactions
Lynch, I., & Dawson, K. A. (2008) · Nano Today · doi:10.1016/s1748-0132(08)70014-8 · Cited by 1,727
Protein−Nanoparticle Interactions: Opportunities and Challenges
Mahmoudi, M., Lynch, I., Ejtehadi, M. R., Monopoli, M. P., Bombelli, F. B., & Laurent, S. (2011) · Chemical Reviews · doi:10.1021/cr100440g · Cited by 1,426
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
Lesniak, A., Fenaroli, F., Monopoli, M. P., Åberg, C., Dawson, K. A., & Salvati, A. (2012) · ACS Nano · doi:10.1021/nn300223w · Cited by 1,020
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 985
Binding of blood proteins to carbon nanotubes reduces cytotoxicity
Ge, C., Du, J., Zhao, L., Wang, L., Liu, Y., Li, D., Yang, Y., Zhou, R., Zhao, Y., Chai, Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105270108 · Cited by 940
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., & Josephson, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1159 · Cited by 904
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Tenzer, S., Docter, D., Rosfa, S., Wlodarski, A., Kuharev, J., Rekik, A., Knauer, S. K., Bantz, C., Nawroth, T., Bier, C., et al. (2011) · ACS Nano · doi:10.1021/nn201950e · Cited by 856
Zhang, H., Ji, Z., Xia, T., Meng, H., Low-Kam, C., Liu, R., Pokhrel, S., Lin, S., Wang, X., Liao, Y.-P., et al. (2012) · ACS Nano · doi:10.1021/nn3010087 · Cited by 825
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W. H., Cohen, Y., Emili, A., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn406018q · Cited by 815
Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles
Puzyn, T., Rasulev, B., Gajewicz, A., Hu, X., Dasari, T. P., Michalkova, A., Hwang, H.-M., Toropov, A., Leszczynska, D., & Leszczynski, J. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.10 · Cited by 790
Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces
Vroman, L., Adams, A., Fischer, G., & Munoz, P. (1980) · Blood · doi:10.1182/blood.v55.1.156.156 · Cited by 781
The Evolution of the Protein Corona around Nanoparticles: A Test Study
Lundqvist, M., Stigler, J., Cedervall, T., Berggård, T., Flanagan, M. B., Lynch, I., Elia, G., & Dawson, K. (2011) · ACS Nano · doi:10.1021/nn202458g · Cited by 752
Soenen, S. J., Rivera-Gil, P., Montenegro, J.-M., Parak, W. J., De Smedt, S. C., & Braeckmans, K. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.001 · Cited by 699
The Impact of Nanoparticle Protein Corona on Cytotoxicity, Immunotoxicity and Target Drug Delivery
Corbo, C., Molinaro, R., Parodi, A., Toledano Furman, N. E., Salvatore, F., & Tasciotti, E. (2016) · Nanomedicine · doi:10.2217/nnm.15.188 · Cited by 692
Dobrovolskaia, M. A., Patri, A. K., Zheng, J., Clogston, J. D., Ayub, N., Aggarwal, P., Neun, B. W., Hall, J. B., & McNeil, S. E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.001 · Cited by 679
Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake
Ritz, S., Schöttler, S., Kotman, N., Baier, G., Musyanovych, A., Kuharev, J., Landfester, K., Schild, H., Jahn, O., Tenzer, S., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00108 · Cited by 619
Lundqvist, M., Sethson, I., & Jonsson, B.-H. (2004) · Langmuir · doi:10.1021/la0484725 · Cited by 597
Hühn, D., Kantner, K., Geidel, C., Brandholt, S., De Cock, I., Soenen, S. J. H., Rivera_Gil, P., Montenegro, J.-M., Braeckmans, K., Müllen, K., et al. (2013) · ACS Nano · doi:10.1021/nn3059295 · Cited by 580
Nanoparticle–Cell Interactions: Molecular Structure of the Protein Corona and Cellular Outcomes
Fleischer, C. C., & Payne, C. K. (2014) · Accounts of Chemical Research · doi:10.1021/ar500190q · Cited by 575
Maiorano, G., Sabella, S., Sorce, B., Brunetti, V., Malvindi, M. A., Cingolani, R., & Pompa, P. P. (2010) · ACS Nano · doi:10.1021/nn101557e · Cited by 573
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
Wang, F., Yu, L., Monopoli, M. P., Sandin, P., Mahon, E., Salvati, A., & Dawson, K. A. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.04.010 · Cited by 427
Quantitative Nanostructure−Activity Relationship Modeling
Fourches, D., Pu, D., Tassa, C., Weissleder, R., Shaw, S. Y., Mumper, R. J., & Tropsha, A. (2010) · ACS Nano · doi:10.1021/nn1013484 · Cited by 388
Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”
Mahon, E., Salvati, A., Baldelli Bombelli, F., Lynch, I., & Dawson, K. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.009 · Cited by 385
Protein corona significantly reduces active targeting yield
Mirshafiee, V., Mahmoudi, M., Lou, K., Cheng, J., & Kraft, M. L. (2013) · Chemical Communications · doi:10.1039/c3cc37307j · Cited by 380
Lindman, S., Lynch, I., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Nano Letters · doi:10.1021/nl062743+ · Cited by 377
Preformed albumin corona, a protective coating for nanoparticles based drug delivery system
Peng, Q., Zhang, S., Yang, Q., Zhang, T., Wei, X.-Q., Jiang, L., Zhang, C.-L., Chen, Q.-M., Zhang, Z.-R., & Lin, Y.-F. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.102 · Cited by 366
Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption
Gessner, A., Waicz, R., Lieske, A., Paulke, B.-R., Mäder, K., & Müller, R. H. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00432-9 · Cited by 358
Temperature: The “Ignored” Factor at the NanoBio Interface
Mahmoudi, M., Abdelmonem, A. M., Behzadi, S., Clement, J. H., Dutz, S., Ejtehadi, M. R., Hartmann, R., Kantner, K., Linne, U., Maffre, P., et al. (2013) · ACS Nano · doi:10.1021/nn305337c · Cited by 333
Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake
Mirshafiee, V., Kim, R., Park, S., Mahmoudi, M., & Kraft, M. L. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.019 · Cited by 316
Personalized protein coronas: a “key” factor at the nanobiointerface
Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F., & Mahmoudi, M. (2014) · Biomaterials Science · doi:10.1039/c4bm00131a · Cited by 307
Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling
Soenen, S. J. H., Himmelreich, U., Nuytten, N., & De Cuyper, M. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.075 · Cited by 302
Petri, B., Bootz, A., Khalansky, A., Hekmatara, T., Müller, R., Uhl, R., Kreuter, J., & Gelperina, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 298
Effect of gold nanoparticle morphology on adsorbed protein structure and function
Gagner, J. E., Lopez, M. D., Dordick, J. S., & Siegel, R. W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.091 · Cited by 297
Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S., & Langer, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.012 · Cited by 262
Perturbational profiling of nanomaterial biologic activity
Shaw, S. Y., Westly, E. C., Pittet, M. J., Subramanian, A., Schreiber, S. L., & Weissleder, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802878105 · Cited by 248
Toward the Development of “Nano‐QSARs”: Advances and Challenges
Puzyn, T., Leszczynska, D., & Leszczynski, J. (2009) · Small · doi:10.1002/smll.200900179 · Cited by 247
Caracciolo, G. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2014.11.003 · Cited by 246
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
Khang, D., Lee, Y. K., Choi, E.-J., Webster, T. J., & Kim, S.-H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s72998 · Cited by 244
Winzen, S., Schoettler, S., Baier, G., Rosenauer, C., Mailaender, V., Landfester, K., & Mohr, K. (2015) · Nanoscale · doi:10.1039/c4nr05982d · Cited by 238
Therapeutic potential of nanoparticulate systems for macrophage targeting
Chellat, F., Merhi, Y., Moreau, A., & Yahia, L. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.044 · Cited by 237
The protein corona of circulating PEGylated liposomes
Palchetti, S., Colapicchioni, V., Digiacomo, L., Caracciolo, G., Pozzi, D., Capriotti, A. L., La Barbera, G., & Laganà, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.012 · Cited by 233
Sacchetti, C., Motamedchaboki, K., Magrini, A., Palmieri, G., Mattei, M., Bernardini, S., Rosato, N., Bottini, N., & Bottini, M. (2013) · ACS Nano · doi:10.1021/nn400409h · Cited by 224
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221
Goy-López, S., Juárez, J., Alatorre-Meda, M., Casals, E., Puntes, V. F., Taboada, P., & Mosquera, V. (2012) · Langmuir · doi:10.1021/la300402w · Cited by 214
Molecular Interaction of Poly(acrylic acid) Gold Nanoparticles with Human Fibrinogen
Deng, Z. J., Liang, M., Toth, I., Monteiro, M. J., & Minchin, R. F. (2012) · ACS Nano · doi:10.1021/nn3029953 · Cited by 203
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Ogawara, K.-I., Furumoto, K., Nagayama, S., Minato, K., Higaki, K., Kai, T., & Kimura, T. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.028 · Cited by 195
Dominguez-Medina, S., Blankenburg, J., Olson, J., Landes, C. F., & Link, S. (2013) · ACS Sustainable Chemistry & Engineering · doi:10.1021/sc400042h · Cited by 194
Yallapu, M. M., Chauhan, N., Othman, S. F., Khalilzad-Sharghi, V., Ebeling, M. C., Khan, S., Jaggi, M., & Chauhan, S. C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.12.045 · Cited by 182
Behzadi, S., Serpooshan, V., Sakhtianchi, R., Müller, B., Landfester, K., Crespy, D., & Mahmoudi, M. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.09.009 · Cited by 177
Protein corona: Opportunities and challenges
Zanganeh, S., Spitler, R., Erfanzadeh, M., Alkilany, A. M., & Mahmoudi, M. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.01.005 · Cited by 176
Classification NanoSAR Development for Cytotoxicity of Metal Oxide Nanoparticles
Liu, R., Rallo, R., George, S., Ji, Z., Nair, S., Nel, A. E., & Cohen, Y. (2011) · Small · doi:10.1002/smll.201002366 · Cited by 174
Protein-Nanoparticle Interactions
Rahman, M., Laurent, S., Tawil, N., Yahia, L., & Mahmoudi, M. (2013) · Springer series in biophysics · doi:10.1007/978-3-642-37555-2 · Cited by 172
Mu, Q., Liu, W., Xing, Y., Zhou, H., Li, Z., Zhang, Y., Ji, L., Wang, F., Si, Z., Zhang, B., et al. (2008) · The Journal of Physical Chemistry C · doi:10.1021/jp710541j · Cited by 170
Tedja, R., Lim, M., Amal, R., & Marquis, C. P. (2012) · ACS Nano · doi:10.1021/nn3004845 · Cited by 160
Bigdeli, A., Palchetti, S., Pozzi, D., Hormozi-Nezhad, M. R., Baldelli Bombelli, F., Caracciolo, G., & Mahmoudi, M. (2016) · ACS Nano · doi:10.1021/acsnano.6b00261 · Cited by 157
Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties
Liu, R., Jiang, W., Walkey, C., Chan, W. C. W., & Cohen, Y. (2015) · Nanoscale · doi:10.1039/c5nr01537e · Cited by 154
Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells
Thiele, L., Diederichs, J. E., Reszka, R. C., Merkle, H. P., & Walter, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00525-2 · Cited by 153
Gräfe, C., Weidner, A., von der Lühe, M., Bergemann, C., Schacher, F. H., Clement, J. H., & Dutz, S. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.005 · Cited by 152
Mirshafiee, V., Kim, R., Mahmoudi, M., & Kraft, M. L. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.019 · Cited by 152
Caracciolo, G., Callipo, L., Sanctis, S. C. D., Cavaliere, C., Pozzi, D., & Laganà, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.11.007 · Cited by 145
Corona-Directed Nucleic Acid Delivery into Hepatic Stellate Cells for Liver Fibrosis Therapy
Zhang, Z., Wang, C., Zha, Y., Hu, W., Gao, Z., Zang, Y., Chen, J., Zhang, J., & Dong, L. (2015) · ACS Nano · doi:10.1021/nn505166x · Cited by 145
Bhogale, A., Patel, N., Mariam, J., Dongre, P. M., Miotello, A., & Kothari, D. C. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.09.021 · Cited by 135
The potential of protein–nanomaterial interaction for advanced drug delivery
Peng, Q., & Mu, H. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.041 · Cited by 134
Gaucher, G., Asahina, K., Wang, J., & Leroux, J. (2009) · Biomacromolecules · doi:10.1021/bm801178f · Cited by 132
Blood protein coating of gold nanoparticles as potential tool for organ targeting
Schäffler, M., Sousa, F., Wenk, A., Sitia, L., Hirn, S., Schleh, C., Haberl, N., Violatto, M. B., Canovi, M., Andreozzi, P., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.100 · Cited by 128
Coating nanoparticles with tunable surfactants facilitates control over the protein corona
Müller, J., Bauer, K. N., Prozeller, D., Simon, J., Mailänder, V., Wurm, F. R., Winzen, S., & Landfester, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.015 · Cited by 128
The influence of nanostructured materials on biointerfacial interactions
Koegler, P., Clayton, A. H. A., Thissen, H. W., Santos, G. N. C., & Kingshott, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.001 · Cited by 125
Crucial Role of the Protein Corona for the Specific Targeting of Nanoparticles
Mahmoudi, M., Sheibani, S., Milani, A. S., Rezaee, F., Gauberti, M., Dinarvand, R., & Vali, H. (2015) · Nanomedicine · doi:10.2217/nnm.14.69 · Cited by 115
Borchard, G., Audus, K. L., Shi, F., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90372-7 · Cited by 105
Arvizo, R. R., Giri, K., Moyano, D. F., Miranda, O. R., Madden, B. J., McCormick, D., Bhattacharya, R., Rotello, V. M., Kocher, J., & Mukherjee, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033650 · Cited by 99
Nanomedicine Delivery: does Protein Corona Route to the Target or off Road?
Maiolo, D., del Pino, P., Metrangolo, P., Parak, W. J., & Bombelli, F. B. (2015) · Nanomedicine · doi:10.2217/nnm.15.163 · Cited by 99
Žūkienė, R., & Snitka, V. J. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.07.054 · Cited by 98
O’Brien, J., & Shea, K. J. (2016) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00125 · Cited by 97
Martel, J., Young, D., Young, A., Wu, C.-Y., Chen, C.-D., Yu, J., & Young, J. D. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.06.018 · Cited by 94
Nanoparticles-cell association predicted by protein corona fingerprints
Palchetti, S., Digiacomo, L., Pozzi, D., Peruzzi, G., Micarelli, E., Mahmoudi, M., & Caracciolo, G. (2016) · Nanoscale · doi:10.1039/c6nr03898k · Cited by 93
The effects of serum on the toxicity of manufactured nanoparticles
Clift, M. J. D., Bhattacharjee, S., Brown, D. M., & Stone, V. (2010) · Toxicology Letters · doi:10.1016/j.toxlet.2010.08.002 · Cited by 89
Serum proteins prevent aggregation of Fe2O3and ZnO nanoparticles
Wells, M. A., Abid, A., Kennedy, I. M., & Barakat, A. I. (2011) · Nanotoxicology · doi:10.3109/17435390.2011.625131 · Cited by 88
Exploiting the Novel Properties of Protein Coronas: Emerging Applications in Nanomedicine
Hamad‐Schifferli, K. (2015) · Nanomedicine · doi:10.2217/nnm.15.6 · Cited by 84
Caracciolo, G., Caputo, D. D., Pozzi, D., Colapicchioni, V., & Coppola, R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.10.008 · Cited by 82
Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation
Xu, F., Reiser, M. L., Yu, X., Gummuluru, S., Wetzler, L. M., & Reinhard, B. M. (2015) · ACS Nano · doi:10.1021/acsnano.5b06501 · Cited by 78
Kendall, M., Ding, P., & Kendall, K. (2010) · Nanotoxicology · doi:10.3109/17435390.2010.489724 · Cited by 75
Determination of Plasma Protein Adsorption on Magnetic Iron Oxides: Sample Preparation
Thode, K., Lück, M., Semmler, W., Müller, R. H., & Kresse, M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012104017761 · Cited by 74
Plasma protein adsorption patterns on liposomes: Establishment of analytical procedure
Diederichs, J. E. (1996) · Electrophoresis · doi:10.1002/elps.1150170332 · Cited by 72
Shubhra, Q. T. H., Tóth, J. S., Gyenis, J., & Feczkó, T. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.07.025 · Cited by 69
Albumin-binding adenoviruses circumvent pre-existing neutralizing antibodies upon systemic delivery
Rojas, L. A., Condezo, G. N., Moreno, R., Fajardo, C. A., Arias-Badia, M., San Martín, C., & Alemany, R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.004 · Cited by 66
Venerando, R., Miotto, G., Magro, M., Dallan, M., Baratella, D., Bonaiuto, E., Zbořil, R., & Vianello, F. (2013) · The Journal of Physical Chemistry C · doi:10.1021/jp4068137 · Cited by 65
Impact of polymer shell on the formation and time evolution of nanoparticle–protein corona
Natte, K., Friedrich, J. F., Wohlrab, S., Lutzki, J., von Klitzing, R., Österle, W., & Orts‐Gil, G. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.11.019 · Cited by 64
Physico-chemical characterization of polysaccharide-coated nanoparticles
Lemarchand, C., Gref, R., Lesieur, S., Hommel, H., Vacher, B., Besheer, A., Mäder, K., & Couvreur, P. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.014 · Cited by 63
Tailoring the stealth properties of biocompatible polysaccharide nanocontainers
Kang, B., Okwieka, P., Schöttler, S., Seifert, O., Kontermann, R. E., Pfizenmaier, K., Musyanovych, A., Meyer, R. G., Diken, M., Şahin, U., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.042 · Cited by 61
Fleischer, C. C., Kumar, U., & Payne, C. K. (2013) · Biomaterials Science · doi:10.1039/c3bm60121h · Cited by 60
Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules
Sánchez‐Moreno, P., Buzón, P., Boulaiz, H., Peula-García, J. M., Ortega-Vinuesa, J. L., Luque, I., Salvati, A. L., & Marchal, J. A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.049 · Cited by 57
Antiadhesive effect of fibrinogen: a safeguard for thrombus stability
Lishko, V. K., Burke, T. A., & Ugarova, T. P. (2006) · Blood · doi:10.1182/blood-2006-05-022764 · Cited by 46
Orts‐Gil, G., Natte, K., Thiermann, R., Girod, M., Rades, S., Kalbe, H., Thünemann, A. F., Maskos, M., & Österle, W. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.02.027 · Cited by 45
Capriotti, A. L., Caracciolo, G., Caruso, G., Foglia, P., Pozzi, D., Samperi, R., & Laganà, A. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.08.003 · Cited by 44
Fibrinogen matrix deposited on the surface of biomaterials acts as a natural anti-adhesive coating
Safiullin, R. A., Christenson, W., Owaynat, H., Yermolenko, I. S., Kadirov, M. K., Ros, R., & Ugarova, T. P. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.007 · Cited by 43
Phagocytosis of immunoglobulin-coated emulsion droplets
M’Barek, K. B., Molino, D., Quignard, S., Plamont, M., Chen, Y., Chavrier, P., & Fattaccioli, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.030 · Cited by 42
Joseph, D., Sachar, S., Kishore, N., & Chandra, S. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.022 · Cited by 40
Protein corona as a proteome fingerprint: The example of hidden biomarkers for cow mastitis
Miotto, G., Magro, M., Terzo, M., Zaccarin, M., Dalt, L. D., Bonaiuto, E., Baratella, D., Gabai, G., & Vianello, F. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.11.043 · Cited by 40
Targeted polymeric therapeutic nanoparticles: Design and interactions with hepatocellular carcinoma
Wang, Q., Sun, Y., Zhang, Z., & Duan, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.03.050 · Cited by 34
An environmental route of exposure affects the formation of nanoparticle coronas in blood plasma
Grunér, M. S., Kauscher, U., Linder, M. B., & Monopoli, M. P. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.10.028 · Cited by 31
Staufenbiel, S., Merino, M., Li, W., Huang, M. D., Baudis, S., Lendlein, A., Müller, R. H., & Wischke, C. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.02.072 · Cited by 27
Kang, T., Park, C., Choi, J.-S., Cui, J.-H., & Lee, B. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.12.001 · Cited by 27
Self-citationCancer cell targeting of lipid gene vectors by protein corona
Caracciolo, G., Pozzi, D., Capriotti, A. L., Cavaliere, C., Cardarelli, F., Bifone, A., Bardi, G., Salomone, F., & Laganà, A. (2012) · IRIS Research product catalog (Sapienza University of Rome) · Cited by 12
Cited by
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Sousa de Almeida, M., Susnik, E., Drasler, B., Taladriz-Blanco, P., Petri-Fink, A., & Rothen-Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,079
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 605
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Spada, A., Emami, J., Tuszynski, J. A., & Lavasanifar, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00046 · Cited by 591
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 548
Metadata
- Authors
- Nguyen, V. H., & Lee, B.-J.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-04
- Volume
- Volume 12
- Pages
- 3137-3151
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2606968610
- Cited by
- 638
- References
- 119
- FWCI
- 22.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.